What is Belhaven Biopharma worth?
$138.7Mlast known valuation
Belhaven Biopharma last raised $32.3M in its Early Stage VC (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Belhaven Biopharma
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Early Stage VC | $32.3M | ▮ | ▮ |
How Belhaven Biopharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Belhaven Biopharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Belhaven Biopharma worth?
- Belhaven Biopharma's last known valuation is $138.7M.
- How much has Belhaven Biopharma raised?
- Belhaven Biopharma has raised $51.2M in total funding across 1 recorded rounds.
- When did Belhaven Biopharma last raise?
- Belhaven Biopharma last raised in Aug 2025 (Early Stage VC), raising $32.3M.